Anti-Angiogenesis Chemotherapy Agents
The role of anti-angiogenesis at cancer treatment
978-3-8454-2009-7
384542009X
80
2011-08-30
49.00 €
eng
https://images.our-assets.com/cover/230x230/9783845420097.jpg
https://images.our-assets.com/fullcover/230x230/9783845420097.jpg
https://images.our-assets.com/cover/2000x/9783845420097.jpg
https://images.our-assets.com/fullcover/2000x/9783845420097.jpg
Angiogenesis can be explained as the growth of new blood vessels from pre-existing vasculature. It has an important and vital role in growth and development, as well as in wound healing. Anti-angiogenic substances suppress the growth of new blood vessels so prevent nutrients and oxygen needed for the growing of tumor cells. It is proposed that tumor angiogenesis could serve as a potential target for anticancer therapy. Combretastatin (CA-4) is an anti-angiogenesis agent that inhibits the tubulin polymerization. CA-4 exhibits anti-tumor effects through the well-organized therapeutic mechanism of tumor blood supply disabling. By affecting selectively and blocking tumor vasculature, CA-4 reduces the blood supply needed for tumor growth and survival. As a result of oxygen poverty and build-up of tumor metabolic by-products causes the death of the cancer cells within the central core of the tumor. In this thesis, covalent modification of CA-4 has been investigated. Variety of CA-4 analogs which involved blocking the free alcohol group has been synthesized.
https://morebooks.de/books/fr/published_by/lap-lambert-academic-publishing/47/products
Chimie
https://morebooks.de/store/fr/book/anti-angiogenesis-chemotherapy-agents/isbn/978-3-8454-2009-7